301 related articles for article (PubMed ID: 33667513)
1. Exercise improves lipid droplet metabolism disorder through activation of AMPK-mediated lipophagy in NAFLD.
Li H; Dun Y; Zhang W; You B; Liu Y; Fu S; Qiu L; Cheng J; Ripley-Gonzalez JW; Liu S
Life Sci; 2021 May; 273():119314. PubMed ID: 33667513
[TBL] [Abstract][Full Text] [Related]
2. Exercise ameliorates lipid droplet metabolism disorder by the PLIN2-LIPA axis-mediated lipophagy in mouse model of non-alcoholic fatty liver disease.
Fang C; Liu S; Yang W; Zheng G; Zhou F; Gao X; Qin L; Yang G; Yang J; Zhu G; Wang X; Huang K; Yang X; Wei Y; Peng S; Li L
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167045. PubMed ID: 38306800
[TBL] [Abstract][Full Text] [Related]
3. Moderate Treadmill Exercise Alleviates NAFLD by Regulating the Biogenesis and Autophagy of Lipid Droplet.
Yang Y; Li X; Liu Z; Ruan X; Wang H; Zhang Q; Cao L; Song L; Chen Y; Sun Y
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432597
[TBL] [Abstract][Full Text] [Related]
4. Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy.
Gao Y; Zhang W; Zeng LQ; Bai H; Li J; Zhou J; Zhou GY; Fang CW; Wang F; Qin XJ
Redox Biol; 2020 Sep; 36():101635. PubMed ID: 32863214
[TBL] [Abstract][Full Text] [Related]
5. Bergamot polyphenol fraction prevents nonalcoholic fatty liver disease via stimulation of lipophagy in cafeteria diet-induced rat model of metabolic syndrome.
Parafati M; Lascala A; Morittu VM; Trimboli F; Rizzuto A; Brunelli E; Coscarelli F; Costa N; Britti D; Ehrlich J; Isidoro C; Mollace V; Janda E
J Nutr Biochem; 2015 Sep; 26(9):938-48. PubMed ID: 26025327
[TBL] [Abstract][Full Text] [Related]
6. Concurrent exercise improves insulin resistance and nonalcoholic fatty liver disease by upregulating PPAR-γ and genes involved in the beta-oxidation of fatty acids in ApoE-KO mice fed a high-fat diet.
Zheng F; Cai Y
Lipids Health Dis; 2019 Jan; 18(1):6. PubMed ID: 30611282
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of stearoyl-coenzyme A desaturase 1 ameliorates hepatic steatosis by inducing AMPK-mediated lipophagy.
Zhou Y; Zhong L; Yu S; Shen W; Cai C; Yu H
Aging (Albany NY); 2020 Apr; 12(8):7350-7362. PubMed ID: 32324591
[TBL] [Abstract][Full Text] [Related]
8. Salvia-Nelumbinis naturalis improves lipid metabolism of NAFLD by regulating the SIRT1/AMPK signaling pathway.
Liu Y; Li Y; Wang J; Yang L; Yu X; Huang P; Song H; Zheng P
BMC Complement Med Ther; 2022 Aug; 22(1):213. PubMed ID: 35945571
[TBL] [Abstract][Full Text] [Related]
9. Terf2ip deficiency accelerates non-alcoholic steatohepatitis through regulating lipophagy and fatty acid oxidation via Sirt1/AMPK pathway.
Wang Y; Liu S; Ni M; Chen Y; Chen R; Wang J; Jiang W; Zhou T; Fan S; Chang J; Xu X; Zhang Y; Yu Y; Li X; Li C
Free Radic Biol Med; 2024 Aug; 220():78-91. PubMed ID: 38697492
[TBL] [Abstract][Full Text] [Related]
10. LB100 ameliorates nonalcoholic fatty liver disease
Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
[TBL] [Abstract][Full Text] [Related]
11. Aerobic training improves NAFLD markers and insulin resistance through AMPK-PPAR-α signaling in obese mice.
Diniz TA; de Lima Junior EA; Teixeira AA; Biondo LA; da Rocha LAF; Valadão IC; Silveira LS; Cabral-Santos C; de Souza CO; Rosa Neto JC
Life Sci; 2021 Feb; 266():118868. PubMed ID: 33310034
[TBL] [Abstract][Full Text] [Related]
12. Exercise regulates lipid droplet dynamics in normal and fatty liver.
la Fuente FP; Quezada L; Sepúlveda C; Monsalves-Alvarez M; Rodríguez JM; Sacristán C; Chiong M; Llanos M; Espinosa A; Troncoso R
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Dec; 1864(12):158519. PubMed ID: 31473346
[TBL] [Abstract][Full Text] [Related]
13. Neuregulin 4 alleviates hepatic steatosis via activating AMPK/mTOR-mediated autophagy in aged mice fed a high fat diet.
Zhu B; Mei W; Jiao T; Yang S; Xu X; Yu H; Ding Y; Guo S; Meng B; Zhao L; He M; Dong K; Guo H; Guo X; Zhang H; Dang R; Xiang G; Wen N
Eur J Pharmacol; 2020 Oct; 884():173350. PubMed ID: 32726654
[TBL] [Abstract][Full Text] [Related]
14. Long-term exercise prevents hepatic steatosis: a novel role of FABP1 in regulation of autophagy-lysosomal machinery.
Pi H; Liu M; Xi Y; Chen M; Tian L; Xie J; Chen M; Wang Z; Yang M; Yu Z; Zhou Z; Gao F
FASEB J; 2019 Nov; 33(11):11870-11883. PubMed ID: 31366243
[TBL] [Abstract][Full Text] [Related]
15. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
[TBL] [Abstract][Full Text] [Related]
16. Protopanaxadiol ameliorates NAFLD by regulating hepatocyte lipid metabolism through AMPK/SIRT1 signaling pathway.
Li Y; Liu Y; Chen Z; Tang K; Yang L; Jiang Y; Wang J; Huang P; Wang J; Zheng P; Song H
Biomed Pharmacother; 2023 Apr; 160():114319. PubMed ID: 36724639
[TBL] [Abstract][Full Text] [Related]
17. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
[TBL] [Abstract][Full Text] [Related]
18. Pterostilbene and Its Derivative 3'-Hydroxypterostilbene Ameliorated Nonalcoholic Fatty Liver Disease Through Synergistic Modulation of the Gut Microbiota and SIRT1/AMPK Signaling Pathway.
Tsai HY; Shih YY; Yeh YT; Huang CH; Liao CA; Hu CY; Nagabhushanam K; Ho CT; Chen YK
J Agric Food Chem; 2022 Apr; 70(16):4966-4980. PubMed ID: 35416649
[TBL] [Abstract][Full Text] [Related]
19. High-altitude chronic hypoxia ameliorates obesity-induced non-alcoholic fatty liver disease in mice by regulating mitochondrial and AMPK signaling.
Song K; Zhang Y; Ga Q; Bai Z; Ge RL
Life Sci; 2020 Jul; 252():117633. PubMed ID: 32289432
[TBL] [Abstract][Full Text] [Related]
20. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
